Cargando…

Severe systemic inflammatory response syndrome in patients following Total aortic arch replacement with deep hypothermic circulatory arrest

BACKGROUND: This cohort study aims to retrospectively investigate the incidence of severe systemic inflammatory response syndrome (sSIRS) in patients following total aortic arch replacement (TAR) under deep hypothermic circulatory arrest (DHCA) with selective cerebral perfusion and its effect on cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jun, Yang, Lijing, Wang, Guyan, Wang, Yuefu, Wang, Chunrong, Shi, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916067/
https://www.ncbi.nlm.nih.gov/pubmed/31842939
http://dx.doi.org/10.1186/s13019-019-1027-3
_version_ 1783480155871641600
author Li, Jun
Yang, Lijing
Wang, Guyan
Wang, Yuefu
Wang, Chunrong
Shi, Sheng
author_facet Li, Jun
Yang, Lijing
Wang, Guyan
Wang, Yuefu
Wang, Chunrong
Shi, Sheng
author_sort Li, Jun
collection PubMed
description BACKGROUND: This cohort study aims to retrospectively investigate the incidence of severe systemic inflammatory response syndrome (sSIRS) in patients following total aortic arch replacement (TAR) under deep hypothermic circulatory arrest (DHCA) with selective cerebral perfusion and its effect on clinical outcomes. METHODS: All patients who underwent TAR with DHCA were consecutively enrolled from January 2013 until December 2015 at our institute. sSIRS was diagnosed between 12 and 48 h postoperatively if patients met all four criteria of the SIRS definition. RESULTS: Of the 522 patients undergoing TAR with DHCA, 31.4% developed sSIRS. Patients aged under 60 yr were characterized by a higher prevalence of sSIRS (OR = 2.93; 95% CI 2.01–4.28; P <0.001). Higher baseline serum creatinine (OR = 1.61; 95% CI 1.18–2.20; P = 0.003), concomitant coronary disease (OR = 2.00; 95% CI 1.15–3.48; P = 0.015) and extended cardiopulmonary time (OR = 1.63; 95% CI 1.23–2.18; P = 0.001) independently contributed to a greater likelihood of postoperative sSIRS onset, while the preferred administration of ulinastatin (OR = 0.69; 95% CI 0.51–0.93; P = 0.015) and dexmedetomidine (OR = 0.36; 95% CI 0.23–0.56; P < 0.001) attenuated it. Patients with sSIRS had a greater risk of developing postoperative major adverse complications compared with the no sSIRS group [56.7%(93/164) vs 26.8% (96/358), P < 0.001]. sSIRS was found to be a significant risk factor for major adverse complications (OR, 4.52; 95% CI, 3.40–6.01; P < 0.001). A significant difference was revealed in in-hospital death following TAR between the sSIRS group and the no-sSIRS group [4.88% (8/164) vs 1.12% (4/358), P = 0.019]. The Kaplan-Meier curve indicated that the time to discharge from the intensive care unit was significantly prolonged in the sSIRS group compared with patients without it (log-rank p < 0.001). CONCLUSIONS: sSIRS occurs commonly in patients following TAR with DHCA. There is an inverse association between age and sSIRS onset, whereby age over 60 yr can lower the risk of it. sSIRS development can increase the likelihood of major postoperative major adverse events.
format Online
Article
Text
id pubmed-6916067
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69160672019-12-30 Severe systemic inflammatory response syndrome in patients following Total aortic arch replacement with deep hypothermic circulatory arrest Li, Jun Yang, Lijing Wang, Guyan Wang, Yuefu Wang, Chunrong Shi, Sheng J Cardiothorac Surg Research Article BACKGROUND: This cohort study aims to retrospectively investigate the incidence of severe systemic inflammatory response syndrome (sSIRS) in patients following total aortic arch replacement (TAR) under deep hypothermic circulatory arrest (DHCA) with selective cerebral perfusion and its effect on clinical outcomes. METHODS: All patients who underwent TAR with DHCA were consecutively enrolled from January 2013 until December 2015 at our institute. sSIRS was diagnosed between 12 and 48 h postoperatively if patients met all four criteria of the SIRS definition. RESULTS: Of the 522 patients undergoing TAR with DHCA, 31.4% developed sSIRS. Patients aged under 60 yr were characterized by a higher prevalence of sSIRS (OR = 2.93; 95% CI 2.01–4.28; P <0.001). Higher baseline serum creatinine (OR = 1.61; 95% CI 1.18–2.20; P = 0.003), concomitant coronary disease (OR = 2.00; 95% CI 1.15–3.48; P = 0.015) and extended cardiopulmonary time (OR = 1.63; 95% CI 1.23–2.18; P = 0.001) independently contributed to a greater likelihood of postoperative sSIRS onset, while the preferred administration of ulinastatin (OR = 0.69; 95% CI 0.51–0.93; P = 0.015) and dexmedetomidine (OR = 0.36; 95% CI 0.23–0.56; P < 0.001) attenuated it. Patients with sSIRS had a greater risk of developing postoperative major adverse complications compared with the no sSIRS group [56.7%(93/164) vs 26.8% (96/358), P < 0.001]. sSIRS was found to be a significant risk factor for major adverse complications (OR, 4.52; 95% CI, 3.40–6.01; P < 0.001). A significant difference was revealed in in-hospital death following TAR between the sSIRS group and the no-sSIRS group [4.88% (8/164) vs 1.12% (4/358), P = 0.019]. The Kaplan-Meier curve indicated that the time to discharge from the intensive care unit was significantly prolonged in the sSIRS group compared with patients without it (log-rank p < 0.001). CONCLUSIONS: sSIRS occurs commonly in patients following TAR with DHCA. There is an inverse association between age and sSIRS onset, whereby age over 60 yr can lower the risk of it. sSIRS development can increase the likelihood of major postoperative major adverse events. BioMed Central 2019-12-16 /pmc/articles/PMC6916067/ /pubmed/31842939 http://dx.doi.org/10.1186/s13019-019-1027-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Li, Jun
Yang, Lijing
Wang, Guyan
Wang, Yuefu
Wang, Chunrong
Shi, Sheng
Severe systemic inflammatory response syndrome in patients following Total aortic arch replacement with deep hypothermic circulatory arrest
title Severe systemic inflammatory response syndrome in patients following Total aortic arch replacement with deep hypothermic circulatory arrest
title_full Severe systemic inflammatory response syndrome in patients following Total aortic arch replacement with deep hypothermic circulatory arrest
title_fullStr Severe systemic inflammatory response syndrome in patients following Total aortic arch replacement with deep hypothermic circulatory arrest
title_full_unstemmed Severe systemic inflammatory response syndrome in patients following Total aortic arch replacement with deep hypothermic circulatory arrest
title_short Severe systemic inflammatory response syndrome in patients following Total aortic arch replacement with deep hypothermic circulatory arrest
title_sort severe systemic inflammatory response syndrome in patients following total aortic arch replacement with deep hypothermic circulatory arrest
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916067/
https://www.ncbi.nlm.nih.gov/pubmed/31842939
http://dx.doi.org/10.1186/s13019-019-1027-3
work_keys_str_mv AT lijun severesystemicinflammatoryresponsesyndromeinpatientsfollowingtotalaorticarchreplacementwithdeephypothermiccirculatoryarrest
AT yanglijing severesystemicinflammatoryresponsesyndromeinpatientsfollowingtotalaorticarchreplacementwithdeephypothermiccirculatoryarrest
AT wangguyan severesystemicinflammatoryresponsesyndromeinpatientsfollowingtotalaorticarchreplacementwithdeephypothermiccirculatoryarrest
AT wangyuefu severesystemicinflammatoryresponsesyndromeinpatientsfollowingtotalaorticarchreplacementwithdeephypothermiccirculatoryarrest
AT wangchunrong severesystemicinflammatoryresponsesyndromeinpatientsfollowingtotalaorticarchreplacementwithdeephypothermiccirculatoryarrest
AT shisheng severesystemicinflammatoryresponsesyndromeinpatientsfollowingtotalaorticarchreplacementwithdeephypothermiccirculatoryarrest